Abstract:ABSTRACT Rotavirus causes severe diarrhea in infants. Although live attenuated rotavirus vaccines are available, vaccine-derived infections have been reported, which warrants development of next-generation rotavirus vaccines. A single-round infectious virus is a promising vaccine platform; however, this platform has not been studied extensively in the context of rotavirus. Here, we aimed to develop a single-round infectious rotavirus by impairing the function of the viral intermediate capsid protein VP6. Recombinant rotaviruses harboring mutations in VP6 were rescued using a reverse genetics system. Mutations were targeted at VP6 residues involved in virion assembly. Although the VP6-mutated rotavirus expressed viral proteins, it did not produce progeny virions in wild-type cells; however, the virus did produce progeny virions in VP6-expressing cells. This indicates that the VP6-mutated rotavirus is a single-round infectious rotavirus. Insertion of a foreign gene, and replacement of the VP7 gene segment with that of human rotavirus clinical isolates, was successful. No infectious virions were detected in mice infected with the single-round infectious rotavirus. Immunizing mice with the single-round infectious rotavirus induced neutralizing antibody titers as high as those induced by wild-type rotavirus. Taken together, the data suggest that this single-round infectious rotavirus has potential as a safe and effective rotavirus vaccine. This system is also applicable for generation of safe and orally administrable viral vectors. IMPORTANCE Rotavirus, a leading cause of acute gastroenteritis in infants, causes an annual estimated 128,500 infant deaths worldwide. Although live attenuated rotavirus vaccines are available, they are replicable and may cause vaccine-derived infections. Thus, development of safe and effective rotavirus vaccine is important. In this study, we report the development of a single-round infectious rotavirus that can replicate only in cells expressing viral VP6 protein. We demonstrated that (1) the single-round infectious rotavirus did not replicate in wild-type cells or in mice; (2) insertion of foreign genes and replacement of the outer capsid gene were possible; and (3) it was as immunogenic as the wild-type virus. Thus, the mutated virus shows promise as a next-generation rotavirus vaccine. The system is also applicable to orally administrable viral vectors, facilitating development of vaccines against other enteric pathogens.

Genetic engineering strategy for generating a stable dsRNA virus vector using a virus-like codon-modified transgene

The Reverse Genetics Systems for Human and Animal RNA Viruses

NOVEL HYBRID GENE VECTOR STABILIZED BY CROSS-LINKING WITH GOLD NANOPARTICLES

Adeno-Associated Virus Engineering and Load Strategy for Tropism Modification, Immune Evasion and Enhanced Transgene Expression

An engineered ligand-responsive Csy4 endoribonuclease controls transgene expression from Sendai virus vectors

Development of an RNA virus-based episomal vector with artificial aptazyme for gene silencing

Lentiviral Delivery of Proteins for Genome Engineering

A rapid and versatile reverse genetics approach for generating recombinant positive-strand RNA viruses that use IRES-mediated translation

Generation of single-round infectious rotavirus with a mutation in the intermediate capsid protein VP6

DNA-Based Nonviral Gene Therapy─Challenging but Promising.

Bioorthogonal Engineered Virus-Like Nanoparticles for Efficient Gene Therapy

High-Efficiency Gene Transfer Mediated by Adenovirus Coupled to DNA–Polylysine Complexes

[A plasmid-based reverse genetics system for rotaviruses]

Establishment of a Dual-Vector System for Gene Delivery Utilizing Prototype Foamy Virus

Sub-genomic flaviviral RNA elements increase the stability and abundance of recombinant AAV vector transcripts

Transgene expression knock-down in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene maintenance across multiple passages

Non-viral vectors for gene-based therapy

New Generation Self-Replicating RNA Vaccines Derived from Pestivirus Genome

Development of Stable Rotavirus Reporter Expression Systems

Versatile strategy using vaccinia virus-capping enzyme to synthesize functional 5' cap-modified mRNAs

Synthetic biology approach to developing all-in-one baculovirus vector using mammalian introns and miRNA binding sites